Helicon Health, a spin out from UCL Business, was last night presented with the Award for ‘One to Watch’ in the 7th Annual UCL Awards for Enterprise 2014.
The Awards were presented at a ceremony and reception at the UCL Bloomsbury Theatre, London. They recognise the efforts and accomplishments of UCL’s innovative and entrepreneurial academics and students. The One to Watch Award specifically recognizes the potential of young company that is displaying excellent business promise.
Helicon Health has developed a unique, cost-saving package of services to help improve outcomes for patients with long-term cardiovascular conditions. Initially focused on stroke prevention, the company’s integrated approach combines patient management tools and advisory systems, with accredited learning and clinical governance. It is a model for the management of all long-term conditions.
David Patterson, chief executive, Helicon Health said:
“We are delighted to receive this accolade and we are hugely grateful to UCL for all the support they have given us over recent years. Helicon Health has come a long way in a short time. Growing numbers of Clinical Commissioning Groups are discovering the benefits of our unique approach and it is great for our team’s work to be recognized in this way.”
To view the Helicon Award video click here or for more information about the UCL Awards for Enterprise please go to www.ucl.ac.uk/enterprise/about/awards/2014
NOTES TO EDITORS
- Helicon Health was spun out of UCL in 2012 as a result of a highly successful service development programme in North London, delivered in partnership with Whittington Health and CHIME (Centre for Health Informatics and Multi-professional education).
- UCL Enterprise provides UCL’s structures for engaging with business for commercial and societal benefit. It includes three units: UCL Advances, UCL Business and UCL Consultants. Together, they provide access to the capabilities and resources of the UCL community to help businesses start, grow and develop.
- UCL Business PLC (UCLB) is an independent, wholly owned subsidiary; it is a technology transfer company, which supports and commercialises research and innovations arising from UCL, one of the UK’s leading research-led universities.
